Indian Journal of Nuclear Medicine

INTERESTING IMAGE
Year
: 2022  |  Volume : 37  |  Issue : 1  |  Page : 94--96

Lewy body dementia associated with anti-iglon 5 encephalitis detected on 18F fluorodeoxyglucose positron emission tomography/computed tomography and 99mtc-trodat single-photon emission computed tomography/computed tomography


Nikhil Seniaray1, Ritu Verma1, Rajeev Ranjan2, Ethel Belho1, Harsh Mahajan1,  
1 Department of Nuclear Medicine and PET/CT, Mahajan Imaging Centre, Sir Ganga Ram Hospital, New Delhi, India
2 Department of Neurology, Sir Ganga Ram Hospital, New Delhi, India

Correspondence Address:
Dr. Nikhil Seniaray
Department of Nuclear Medicine and PET/CT, Mahajan Imaging Centre, Sir Ganga Ram, Hospital, New Delhi
India

Abstract

We present a case of Anti-IgLON 5 encephalitis with Lewy body dementia. 18F fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) scan and 99 mTc-TRODAT-1 SPECT/CT scan were done. 99 mTc-TRODAT-1 scan findings revealed severely reduced concentration of dopamine transporter in bilateral basal ganglia, suggestive of a degenerative parkinsonian disorder. 18F-FDG PET scan findings were suggestive of moderate-to-severe hypometabolism in the bilateral parieto-temporal and bilateral occipital cortices including the primary visual cortices, supporting Lewy body spectrum disease with associated hypermetabolism in the bilateral sensorimotor cortices, bilateral basal ganglia, thalami, brain stem, and bilateral cerebellar hemispheres suggestive of inflammatory pathology.



How to cite this article:
Seniaray N, Verma R, Ranjan R, Belho E, Mahajan H. Lewy body dementia associated with anti-iglon 5 encephalitis detected on 18F fluorodeoxyglucose positron emission tomography/computed tomography and 99mtc-trodat single-photon emission computed tomography/computed tomography.Indian J Nucl Med 2022;37:94-96


How to cite this URL:
Seniaray N, Verma R, Ranjan R, Belho E, Mahajan H. Lewy body dementia associated with anti-iglon 5 encephalitis detected on 18F fluorodeoxyglucose positron emission tomography/computed tomography and 99mtc-trodat single-photon emission computed tomography/computed tomography. Indian J Nucl Med [serial online] 2022 [cited 2022 Jun 26 ];37:94-96
Available from: https://www.ijnm.in/text.asp?2022/37/1/94/340855


Full Text



we present a case of a 76 year old gentleman male who presented with complains of progressive impairment of memory for 1 year, visual hallucinations with delusions of persecution for 9 months, progressive instability of gait with recurrent falls and urinary incontinence for 6 months, and difficulty in speaking and swallowing of 3 months' duration. He developed loud stridor while breathing for 1 month with disturbed sleep and constant leg movements while lying down along with recurrent episodes of breath-holding with a few episodes of witnessed apneas. He was brought to the hospital with complains of progressively worsening altered sensorium of a few days' duration. On examination, he was found to be drowsy, lethargic, and confused with GCS E2M6V4-12/15, irregular respiration with apneic spells. There was the restriction of vertical eye movements, slowing of saccades and breaking of pursuits with spastic dysarthric speech, drooling of saliva, unstable gait with, increased tone in all four limbs, and bilateral extensor plantar responses; however, there were no cerebellar signs.

Suspecting neurodegenerative and inflammatory pathology, magnetic resonance imaging (MRI) scan was done initially which was unremarkable [Figure 1]. 99 mTc-TRODAT-1 scan was done to rule out Parkinson and Parkinson plus syndromes revealed severely reduced concentration of dopamine transporter suggestive of Parkinsonian syndrome [Figure 2]. 18F fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) scan was done for further characterization. 18F-FDG PET [Figure 3] revealed moderate-to-severe hypometabolism in the bilateral parieto-temporal and bilateral occipital cortices including the primary visual cortices, suggestive of Lewy body spectrum disease; however, there was associated hypermetabolism in the bilateral sensorimotor cortices, bilateral basal ganglia, thalami, brain stem, and bilateral cerebellar hemispheres which were likely due inflammatory pathology. Statistical parametric mapping (SPM) was done to confirm 18F-FDG PET findings. SPM images were co-registered to a normal axial MRI [Figure 4] showing the areas of hypometabolism (Blue) and hypermetabolism (Red). Antibodies to a neuronal cell adhesion protein IgLON5 were found positive in the cerebrospinal fluid (CSF) and serum. Thus, the diagnosis of IgLON5 encephalitis with Lewy body dementia was established. The patient condition improved after immunoglobulin treatment and the clinical symptoms of the oral discomfort and involuntary movements of mouth were gradually alleviated, and her gait became normal. Anti-IgLON5 disease is a prominent sleep disorder with progressive bulbar dysfunction, gait instability, and abnormal eye movements with cognitive deterioration.[1],[2],[3] CSF and serum harbors antibodies against IgLON5 with neuronal-specific tau accumulation.[4],[5] The brain metabolic pattern of this patient was similar to the case reported by Zhang et al.;[6] however, in our case, overlap was seen between degenerative parkinsonian disorder and anti-IgLON5 antibody-mediated encephalitis. Very few overlap syndromes with IgLON 5 encephalitis have been reported in the literature.[7],[8] The 18F-FDG PET/CT with 99 mTc-TRODAT-1 scan may have a potential role in establishing the diagnosis of overlapping syndromes of degenerative Parkinsonian disorders with encephalitis and help to monitor response to treatment.[9],[10]{Figure 1}{Figure 2}{Figure 3}{Figure 4}

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: A case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 2014;13:575-86.
2Högl B, Heidbreder A, Santamaria J, Graus F, Poewe W. IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet 2015;385:1590.
3Simabukuro MM, Sabater L, Adoni T, Cury RG, Haddad MS, Moreira CH, et al. Sleep disorder, chorea, and dementia associated with IgLON5 antibodies. Neurol Neuroimmunol Neuroinflamm 2015;2:e136.
4Della Marca G, Iorio R, Losurdo A, Mirabella M, Frisullo G. Sleep disorder associated with antibodies to IgLON5: Parasomnia or agrypnia? Lancet Neurol 2014;13:864.
5Balint B, Bhatia KP. Friend or foe? IgLON5 antibodies in a novel tauopathy with prominent sleep movement disorder, ataxia, and chorea. Mov Disord 2014;29:989.
6Zhang W, Niu N, Cui R. Serial 18F-FDG PET/CT findings in a patient with IgLON5 encephalopathy. Clin Nucl Med 2016;41:787-8.
7Haitao R, Yingmai Y, Yan H, Fei H, Xia L, Honglin H, et al. Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy. J Neuroimmunol 2016;300:9-10.
8Montagna M, Amir R, De Volder I, Lammens M, Huyskens J, Willekens B. IgLON5-associated encephalitis with atypical brain magnetic resonance imaging and cerebrospinal fluid changes. Front Neurol 2018;9:329.
9Quartuccio N, Caobelli F, Evangelista L, Alongi P, Kirienko M, De Biasi V, et al. The role of PET/CT in the evaluation of patients affected by limbic encephalitis: A systematic review of the literature. J Neuroimmunol 2015;284:44-8.
10Trevino-Peinado C, Arbizu J, Irimia P, Riverol M, Martínez-Vila E. Monitoring the effect of immunotherapy in autoimmune limbic encephalitis using 18F-FDG PET. Clin Nucl Med 2015;40:e441-3.